vanoxerine has been researched along with citalopram in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.55) | 18.7374 |
| 1990's | 8 (36.36) | 18.2507 |
| 2000's | 9 (40.91) | 29.6817 |
| 2010's | 4 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
| Chilco, PJ; Donnan, GA; Kaczmarczyk, SJ; Kalnins, RM; Mendelsohn, FA; Paxinos, G; Woodhouse, DG | 1 |
| Aalto, J; Kiianmaa, K | 1 |
| Spealman, RD | 1 |
| al-Tikriti, MS; Baldwin, RM; Laruelle, M; Malison, RT; Neumeyer, JL; Sybirska, EH; Wisniewski, G; Zea-Ponce, Y; Zimmermann, RC; Zoghbi, SS | 1 |
| Dutta, AK; Madras, BK; Meltzer, PC; Reith, ME | 1 |
| Hashimoto, S; Inoue, T; Izumi, T; Koyama, T; Ohmori, T; Tsuchiya, K | 1 |
| Coffey, LL; Dutta, AK; Reith, ME | 1 |
| Dutta, AK; Reith, ME; Xu, C | 1 |
| Besnard, JC; Bottlaender, M; Chalon, S; Coulon, C; Emond, P; Frangin, Y; Fuseau, C; Guenther, I; Guilloteau, D; Helfenbein, J; Loc'h, C; Maziere, B; Ottaviani, M | 1 |
| Bergman, J; Gasior, M; Paronis, CA | 1 |
| Platt, DM; Rowlett, JK; Spealman, RD | 1 |
| Clinckers, R; Ebinger, G; Meurs, A; Michotte, Y; Smolders, I | 1 |
| Bordet, R; Derambure, P; Destée, A; Jacquesson, JM; Laloux, C; Monaca, C | 1 |
| Brooks, BW; Frazer, A; Gould, GG | 1 |
| Kehr, J; Scheel-Krüger, J; Weikop, P | 1 |
| Clinckers, R; De Bundel, D; Ebinger, G; Meurs, A; Michotte, Y; Portelli, J; Smolders, I | 1 |
| Bari, A; Eagle, DM; Mar, AC; Robbins, TW; Robinson, ES | 1 |
| Finnema, SJ; Guilloteau, D; Gulyás, B; Halldin, C; Schou, M; Steiger, C; Takano, A; Varrone, A | 1 |
| Abela, AR; Chudasama, Y; Dougherty, SD; Fagen, ED; Hill, CJ | 1 |
| Alsiö, J; Barlow, RL; Dalley, JW; Jupp, B; Rabinovich, R; Robbins, TW; Roberts, AC; Shrestha, S | 1 |
| Averbeck, BB; Costa, VD; Kakalios, LC | 1 |
22 other study(ies) available for vanoxerine and citalopram
| Article | Year |
|---|---|
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
Distribution of catecholamine uptake sites in human brain as determined by quantitative [3H] mazindol autoradiography.
Topics: Aged; Benztropine; Binding, Competitive; Biological Transport; Brain Chemistry; Brain Mapping; Caudate Nucleus; Citalopram; Clomipramine; Corpus Striatum; Desipramine; Dopamine; Humans; Locus Coeruleus; Mazindol; Medulla Oblongata; Mianserin; Middle Aged; Norepinephrine; Piperazines; Pons; Substantia Nigra | 1991 |
Role of brain monoaminergic systems in the increased ethanol drinking caused by REM-sleep deprivation.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alcohol Drinking; Animals; Brain Chemistry; Catecholamines; Citalopram; Dopamine; Hydroxyindoleacetic Acid; Hypothalamus; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Piperazines; Prazosin; Propylamines; Rats; Serotonin; Sleep Deprivation; Sleep, REM; Thiophenes | 1987 |
Noradrenergic involvement in the discriminative stimulus effects of cocaine in squirrel monkeys.
Topics: Adrenergic Agonists; Adrenergic Antagonists; Animals; Citalopram; Cocaine; Discrimination Learning; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Male; Narcotics; Neurotransmitter Uptake Inhibitors; Norepinephrine; Piperazines; Receptors, Adrenergic, alpha; Saimiri; Selective Serotonin Reuptake Inhibitors | 1995 |
SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates.
Topics: Animals; Brain; Brain Chemistry; Carrier Proteins; Chlorocebus aethiops; Citalopram; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Indans; Iodine Radioisotopes; Levodopa; Ligands; Maprotiline; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neurotransmitter Uptake Inhibitors; Papio; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Tomography, Emission-Computed, Single-Photon | 1993 |
O-526, a piperidine analog of GBR 12909, retains high affinity for the dopamine transporter in monkey caudate-putamen.
Topics: Animals; Carrier Proteins; Caudate Nucleus; Citalopram; Cocaine; Dopamine Plasma Membrane Transport Proteins; In Vitro Techniques; Macaca fascicularis; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neurotransmitter Uptake Inhibitors; Piperazines; Piperidines; Protein Binding; Putamen; Serotonin; Serotonin Plasma Membrane Transport Proteins | 1994 |
Effect of citalopram, a selective serotonin reuptake inhibitor, on the acquisition of conditioned freezing.
Topics: Adrenergic Uptake Inhibitors; Animals; Behavior, Animal; Citalopram; Conditioning, Psychological; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Electroshock; Fear; Male; Piperazines; Pyridines; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Stress, Psychological | 1996 |
Highly selective, novel analogs of 4-[2-(diphenylmethoxy)ethyl]- 1-benzylpiperidine for the dopamine transporter: effect of different aromatic substitutions on their affinity and selectivity.
Topics: Animals; Carrier Proteins; Citalopram; Cocaine; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Piperazines; Rats | 1997 |
Tolerance in the replacement of the benzhydrylic O atom in 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives by an N atom: development of new-generation potent and selective N-analogue molecules for the dopamine transporter.
Topics: Animals; Carrier Proteins; Cell Line; Citalopram; Cloning, Molecular; Cocaine; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Drug Design; Humans; Ligands; Membrane Glycoproteins; Membrane Transport Proteins; Molecular Structure; Nerve Tissue Proteins; Piperazines; Piperidines; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Serotonin; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship; Transfection | 1998 |
A selective radiobrominated cocaine analogue for imaging of dopamine uptake sites: pharmacological evaluation and PET experiments.
Topics: Animals; Brain; Bromine Radioisotopes; Cerebellum; Cerebral Cortex; Citalopram; Cocaine; Corpus Striatum; Dopamine; Kinetics; Male; Maprotiline; Nortropanes; Papio; Piperazines; Radiopharmaceuticals; Rats; Rats, Wistar; Thalamus; Tissue Distribution; Tomography, Emission-Computed | 1999 |
Modification by dopaminergic drugs of choice behavior under concurrent schedules of intravenous saline and food delivery in monkeys.
Topics: Animals; Benzazepines; Choice Behavior; Citalopram; Desipramine; Discrimination Learning; Dopamine Agents; Female; Food; Macaca mulatta; Male; Membrane Glycoproteins; Membrane Transport Proteins; Neuropeptides; Piperazines; Receptors, Dopamine D1; Receptors, Dopamine D2; Self Administration; Sodium Chloride; Vesicular Biogenic Amine Transport Proteins | 2004 |
Cocaine-like discriminative stimulus effects of heroin: modulation by selective monoamine transport inhibitors.
Topics: Animals; Carrier Proteins; Citalopram; Cocaine; Discrimination, Psychological; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Drug Interactions; Heroin; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neuropeptides; Norepinephrine Plasma Membrane Transport Proteins; Piperazines; Prazosin; Receptors, Adrenergic, alpha-1; Saimiri; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Symporters; Thiophenes; Vesicular Biogenic Amine Transport Proteins | 2004 |
Anticonvulsant action of GBR-12909 and citalopram against acute experimentally induced limbic seizures.
Topics: Acute Disease; Animals; Anticonvulsants; Biogenic Monoamines; Citalopram; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Hippocampus; Limbic System; Male; Microdialysis; Muscarinic Agonists; Pilocarpine; Piperazines; Pyridines; Rats; Rats, Wistar; Remoxipride; Seizures; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists | 2004 |
The effects of serotoninergic, noradrenergic, cholinergic and dopaminergic drugs on vigilance states in MPTP-treated mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acyclovir; Adrenergic Uptake Inhibitors; Animals; Arecoline; Arousal; Behavior, Animal; Cholinergic Agonists; Citalopram; Desipramine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred C57BL; Neurotoxins; Neurotransmitter Uptake Inhibitors; Piperazines; Selective Serotonin Reuptake Inhibitors; Time Factors; Tyrosine 3-Monooxygenase | 2007 |
[(3)H] citalopram binding to serotonin transporter sites in minnow brains.
Topics: Animals; Brain; Chlorpyrifos; Cholinesterase Inhibitors; Citalopram; Cyprinidae; Desipramine; Dopamine Uptake Inhibitors; Male; Norepinephrine Plasma Membrane Transport Proteins; Piperazines; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline | 2007 |
Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors.
Topics: Adrenergic Uptake Inhibitors; Animals; Citalopram; Cyclohexanols; Dopamine; Dopamine Uptake Inhibitors; Male; Methylphenidate; Microdialysis; Norepinephrine; Piperazines; Prefrontal Cortex; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride | 2007 |
Direct enhancement of hippocampal dopamine or serotonin levels as a pharmacodynamic measure of combined antidepressant-anticonvulsant action.
Topics: Animals; Anticonvulsants; Antidepressive Agents; Antidepressive Agents, Tricyclic; Chromatography, Liquid; Citalopram; Dopamine; Dopamine Uptake Inhibitors; GABA Antagonists; Hindlimb Suspension; Hippocampus; Indicators and Reagents; Male; Mice; Microdialysis; Motor Activity; Piperazines; Rats; Rats, Wistar; Receptors, Glutamate; Receptors, Metabotropic Glutamate; Seizures; Selective Serotonin Reuptake Inhibitors; Serotonin; Swimming | 2008 |
Dissociable effects of noradrenaline, dopamine, and serotonin uptake blockade on stop task performance in rats.
Topics: Analysis of Variance; Animals; Atomoxetine Hydrochloride; Behavior, Animal; Citalopram; Conditioning, Operant; Dopamine; Dose-Response Relationship, Drug; Guanfacine; Inhibition, Psychological; Male; Neurotransmitter Uptake Inhibitors; Norepinephrine; Piperazines; Propylamines; Rats; Reaction Time; Selective Serotonin Reuptake Inhibitors; Serotonin; Task Performance and Analysis; Time Factors | 2009 |
In vitro autoradiography and in vivo evaluation in cynomolgus monkey of [18F]FE-PE2I, a new dopamine transporter PET radioligand.
Topics: Animals; Autoradiography; Binding, Competitive; Brain; Citalopram; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Macaca fascicularis; Metabolic Clearance Rate; Nortropanes; Piperazines; Positron-Emission Tomography; Postmortem Changes; Protein Binding; Radiopharmaceuticals; Selective Serotonin Reuptake Inhibitors; Tissue Distribution | 2009 |
Inhibitory control deficits in rats with ventral hippocampal lesions.
Topics: Analysis of Variance; Animals; Attention; Choice Behavior; Citalopram; Discrimination, Psychological; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Food Preferences; Hippocampus; Impulsive Behavior; Inhibition, Psychological; Male; Photic Stimulation; Piperazines; Rats; Rats, Long-Evans; Reaction Time; Reversal Learning; Selective Serotonin Reuptake Inhibitors; Sucrose; Sweetening Agents | 2013 |
Markers of serotonergic function in the orbitofrontal cortex and dorsal raphé nucleus predict individual variation in spatial-discrimination serial reversal learning.
Topics: Animals; Citalopram; Conditioning, Operant; Discrimination, Psychological; Dorsal Raphe Nucleus; Dose-Response Relationship, Drug; Gene Expression; Male; Monoamine Oxidase; Piperazines; Prefrontal Cortex; Protein Binding; Rats; Reinforcement, Psychology; Reversal Learning; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin; Space Perception; Tryptophan Hydroxylase | 2015 |
Blocking serotonin but not dopamine reuptake alters neural processing during perceptual decision making.
Topics: Animals; Behavior, Animal; Citalopram; Decision Making; Dopamine; Dopamine Uptake Inhibitors; Impulsive Behavior; Macaca mulatta; Male; Piperazines; Reaction Time; Selective Serotonin Reuptake Inhibitors; Serotonin | 2016 |